Turkey · Delayed Price · Currency is TRY IST:MEDTR Statistics
Total Valuation
IST:MEDTR has a market cap or net worth of TRY 2.92 billion. The enterprise value is 2.50 billion.
| Market Cap | 2.92B |
| Enterprise Value | 2.50B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | Dec 28, 2026 |
Share Statistics
IST:MEDTR has 119.00 million shares outstanding.
| Current Share Class | 95.38M |
| Shares Outstanding | 119.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 79.41% |
| Owned by Institutions (%) | 3.11% |
| Float | 24.50M |
Valuation Ratios
The trailing PE ratio is 81.87.
| PE Ratio | 81.87 |
| Forward PE | n/a |
| PS Ratio | 1.14 |
| PB Ratio | 0.86 |
| P/TBV Ratio | 0.89 |
| P/FCF Ratio | 8.84 |
| P/OCF Ratio | 5.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.77, with an EV/FCF ratio of 7.55.
| EV / Earnings | 68.55 |
| EV / Sales | 0.97 |
| EV / EBITDA | 10.77 |
| EV / EBIT | 47.24 |
| EV / FCF | 7.55 |
Financial Position
The company has a current ratio of 3.76, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.76 |
| Quick Ratio | 2.28 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.08 |
| Interest Coverage | 1.74 |
Financial Efficiency
Return on equity (ROE) is 1.34% and return on invested capital (ROIC) is 1.97%.
| Return on Equity (ROE) | 1.34% |
| Return on Assets (ROA) | 0.96% |
| Return on Invested Capital (ROIC) | 1.97% |
| Return on Capital Employed (ROCE) | 1.59% |
| Weighted Average Cost of Capital (WACC) | 7.23% |
| Revenue Per Employee | 3.35M |
| Profits Per Employee | 47,396 |
| Employee Count | 768 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 2.78 |
Taxes
| Income Tax | -101.50M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.62% in the last 52 weeks. The beta is 0.39, so IST:MEDTR's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -18.62% |
| 50-Day Moving Average | 26.43 |
| 200-Day Moving Average | 28.55 |
| Relative Strength Index (RSI) | 35.30 |
| Average Volume (20 Days) | 296,180 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IST:MEDTR had revenue of TRY 2.57 billion and earned 36.40 million in profits. Earnings per share was 0.30.
| Revenue | 2.57B |
| Gross Profit | 752.90M |
| Operating Income | 55.65M |
| Pretax Income | -61.91M |
| Net Income | 36.40M |
| EBITDA | 224.32M |
| EBIT | 55.65M |
| Earnings Per Share (EPS) | 0.30 |
Balance Sheet
The company has 484.26 million in cash and 27.91 million in debt, with a net cash position of 456.35 million or 3.83 per share.
| Cash & Cash Equivalents | 484.26M |
| Total Debt | 27.91M |
| Net Cash | 456.35M |
| Net Cash Per Share | 3.83 |
| Equity (Book Value) | 3.39B |
| Book Value Per Share | 28.23 |
| Working Capital | 1.46B |
Cash Flow
In the last 12 months, operating cash flow was 540.35 million and capital expenditures -209.70 million, giving a free cash flow of 330.65 million.
| Operating Cash Flow | 540.35M |
| Capital Expenditures | -209.70M |
| Depreciation & Amortization | 168.67M |
| Net Borrowing | -20.12M |
| Free Cash Flow | 330.65M |
| FCF Per Share | 2.78 |
Margins
Gross margin is 29.24%, with operating and profit margins of 2.16% and 1.41%.
| Gross Margin | 29.24% |
| Operating Margin | 2.16% |
| Pretax Margin | -2.40% |
| Profit Margin | 1.41% |
| EBITDA Margin | 8.71% |
| EBIT Margin | 2.16% |
| FCF Margin | 12.84% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 1.01%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 1.01% |
| Dividend Growth (YoY) | 35.01% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 103.75% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.01% |
| Earnings Yield | 1.25% |
| FCF Yield | 11.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 22, 2022. It was a forward split with a ratio of 3.5.
| Last Split Date | Feb 22, 2022 |
| Split Type | Forward |
| Split Ratio | 3.5 |
Scores
IST:MEDTR has an Altman Z-Score of 4.84 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.84 |
| Piotroski F-Score | 5 |